This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 3 EPO patents. Top assignee: Euroimmun Medizinische Labordiagnostika Ag. Active years: 2020-2023.
Company Filing History:
Years Active: 2020-2023
Title: The Innovations of Erik Lattwein
Introduction
Erik Lattwein is a notable inventor based in Lübeck, Germany. He has made significant contributions to the field of medical diagnostics, particularly in the detection of viral infections. With a total of three patents to his name, Lattwein's work has the potential to impact public health positively.
Latest Patents
Lattwein's latest patents focus on immunoassays for the diagnosis of viral infections. One of his key inventions involves a recombinant polypeptide that can be utilized in diagnosing the presence of the Zika virus in patients. This recombinant polypeptide includes SEQ ID NO: 1 or a variant thereof and can exist as a monomer, dimer, or hexamer. His innovative approach aims to enhance the accuracy and efficiency of viral infection diagnostics.
Career Highlights
Throughout his career, Erik Lattwein has worked with prominent organizations such as Euroimmun Medizinische Labordiagnostika AG and Charité - Universitätsmedizin Berlin. His experience in these institutions has allowed him to develop and refine his inventions, contributing to advancements in medical technology.
Collaborations
Lattwein has collaborated with several professionals in his field, including Katja Steinhagen and Andrea Deerberg. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Erik Lattwein's contributions to medical diagnostics through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in the detection of viral infections, showcasing the importance of innovation in healthcare.